Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2553-2563
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2553
Table 1 Clinicopathologic characteristics of included patients before and after propensity score matching
VariablesBefore PSM
After PSM
GSC (n = 178)
PGC (n = 957)
χ2/Z
P value
GSC (n = 152)
PGC (n = 152)
χ2/Z
P value
Gender0.2220.6380.0170.895
    Female442213839
    Male134736114113
Age (yr)0.4520.5020.0200.0889
    > 55127706120119
    ≤ 55512513233
Tumor size2.3000.1292.6080.106
    > 3.5 cm1036119177
    ≤ 3.5 cm753466175
ASA grade2.5900.1080.0580.809
    I/II11254099101
    III/IV664175351
Hospital stay after surgery (d)12.65 ± 5.1312.77 ± 4.421.0230.13311.13 ± 4.7111.45 ± 5.901.1560.232
Blood transfusion10.7050.0012.1140.156
    Yes421273457
    No12678010885
Vascular invasion0.4050.5250.9200.337
    Positive363393270
    Negative514154982
    Missing9120371-
Nerve invasion0.4750.4910.2800.596
    Positive493894063
    Negative553784989
    Missing7419063-
Differentiation degree18.5370.0001.4520.028
    High/median381002721
    Low128824115131
    Missing123310-
Depth of infiltration0.3100.5780.8380.360
    T1/T2401983643
    T3/T4138762116109
Number of lymph nodes3.8590.0496.7520.009
    ≥ 710161794115
    < 7773405837
Positive lymph nodes0.5700.45019.6670.000
    ≥ 38643371109
    < 3925248143
TNM stage10.3670.0060.0620.969
    I151321718
    II431683839
    III946579795
Table 2 Univariate analysis of cancer-specific survival in gastric stump cancer and proximal gastric cancer
VariablesGSC
PGC
n = 152
HR
95%CI
P value
n = 152
HR
95%CI
P value
Gender1.9910.937-3.4220.038a1.9910.937-3.4220.038a
    Female3838
    Male114114
Age (yr)1.1170.681-1.8330.9001.1110.690-1.8040.893
    > 55120119
    ≤ 553233
Tumor size1.0120.622-1.6460.9611.4050.598-1.8370.902
    > 3.5 cm9177
    ≤ 3.5 cm6175
ASA grade1.3380.792-2.2600.2761.2570.777-2.9000.331
    I/II99101
    III/IV5351
Hospital stay after surgery (d)11.13 ± 4.710.6350.308-1.3070.21812.45 ± 5.900.8730.299-1.7800.412
Blood transfusion1.1140.655-1.8960.6901.2960.588-2.0010.255
    Yes4467
    No10885
Vascular invasion1.6620.210-2.1380.6301.6031.000-9.5680.049a
    Positive3270
    Negative4982
    Missing71-
Nerve invasion1.7100.971-3.0120.0634.6600.981-22.1340.053
    Positive4063
    Negative4989
    Missing63-
Differentiation degree2.7141.603-4.5960.000a3.5031.734-11.3850.000a
    High/median2721
    Low115131
    Missing10-
Depth of infiltration3.6142.290-4.2890.0802.3320.074-4.4980.041a
    T1/T23643
    T3/T4116109
Number of lymph nodes0.7920.336-1.8690.5953.4320.874-12.4410.077
    ≥ 794115
    < 75837
Positive lymph nodes0.2230.110-0.8810.1240.4850.260-0.9060.023a
    ≥ 371109
    < 38143
TNM stage5.7272.579- 12.7150.000a5.4462.555-11.9920.000a
    I1718
    II3839
    III9795
Table 3 Multivariate analysis of factors affecting cancer-specific survival
GSC
PGC
HR
95%CI
P value
HR
95%CI
P value
Gender1.5520.129-3.4280.0581.8470.135-2.9900.043
Differentiation degree1.4301.055-1.9380.021a1.9990.636-3.0040.027a
Depth of infiltration2.9291.383-4.6910.000a
Positive lymph nodes2.4521.085-3.9420.012a
TNM stage1.4261.040-1.9550.027a2.7711.448-4.6620.000a
Vascular invasion1.2690.680-3.9980.070